Guided Therapeutics (GTHP) Gross Profit Growth (1y) (2013 - 2025)
Guided Therapeutics (GTHP) Gross Profit Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 8.95% |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23,000.00% |
| Dec 31, 2024 | -112.50% |
| Mar 31, 2024 | -69.23% |
| Dec 31, 2023 | 120.25% |
| Sep 30, 2023 | -233.33% |
| Jun 30, 2023 | 175.00% |
| Mar 31, 2023 | 225.00% |
| Dec 31, 2022 | -292.68% |
| Sep 30, 2022 | 113.04% |
| Jun 30, 2022 | 100.00% |
| Dec 31, 2021 | -51.76% |
| Sep 30, 2021 | -135.38% |
| Jun 30, 2021 | 133.33% |
| Dec 31, 2020 | 608.33% |
| Sep 30, 2020 | 6,400.00% |
| Jun 30, 2020 | 90.63% |
| Dec 31, 2019 | 127.27% |
| Sep 30, 2019 | -50.00% |
| Jun 30, 2019 | -1,014.29% |
| Mar 31, 2019 | 1,600.00% |